HCM
CNMD icon

Highbridge Capital Management’s CONMED CNMD Stock Holding History

Highbridge Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,426
Closed -$374K – 1296
2017
Q1 		$374K Buy
+8,426
New +$362K 0.01% 1039
2014
Q2 		– Sell
-15,212
Closed -$661K – 1083
2014
Q1 		$661K Buy
+15,212
New +$678K 0.01% 641

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Highbridge Capital Management's CNMD Position: Q2 2017 in Review

Highbridge Capital Management sold out of CONMED (CNMD) in Q2 2017, closing a stake of 8,426 shares — an estimated $374K sold.

Highbridge Capital Management first reported a position in CNMD in Q1 2014 and held it in 2 quarters. The position peaked at $661K in Q1 2014. 150 funds tracked by Wall St. Rank hold CNMD as of Q2 2017.

  • Highbridge Capital Management reported no remaining CONMED position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 8,426 CONMED shares in Q2 2017, an estimated $374K.
  • Highbridge Capital Management first reported a position in CONMED in Q1 2014 and held it in 2 quarters.
  • Highbridge Capital Management's CONMED position peaked at $661K in Q1 2014.
  • 150 funds tracked by Wall St. Rank held CONMED as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.